Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOld Mutual Lim. Regulatory News (OMU)

Share Price Information for Old Mutual Lim. (OMU)

Share Price is delayed by 15 minutes
Get Live Data
60.80    -1.00 (-1.62%)
Bid:
60.00
Ask:
61.20
Spread: 1.20 (2.00%)
Market Cap: £2.43b
OMU Live PriceLast checked at - London Stock Exchange

Intraday Old Mutual Lim. Share Chart

Trading Statement

23 Feb 2022 07:00

RNS Number : 5392C
Old Mutual Limited
23 February 2022
 

Old Mutual Limited

Incorporated in the Republic of South Africa

Registration number: 2017/235138/06

ISIN: ZAE000255360

LEI: 213800MON84ZWWPQCN47

JSE Share Code: OMU

LSE Share Code: OMU

NSX Share Code: OMM

MSE Share Code: OMU

ZSE Share Code: OMU

("Old Mutual" or "Company" or "Group")

 

Ref 01/22

23 February 2022

 

OLD MUTUAL TRADING STATEMENT FOR THE YEAR ENDED 31 DECEMBER 2021

 

Shareholders are advised that Old Mutual is currently in the process of finalising its annual results for the year ended 31 December 2021 ("current period"), which will be released on the Stock Exchange News Service of the JSE Limited on Tuesday, 15 March 2022. This trading statement provides an indication of a range for headline earnings per ordinary share (HEPS) and earnings attributable to equity holders of the Group per ordinary share (EPS) in terms of paragraph 3.4(b) of the JSE Limited Listings Requirements compared to the year ended 31 December 2020 ("comparative period").

 

The Group's operational and financial performance in 2021 demonstrated a strong recovery from the impacts of the COVID-19 pandemic. The relaxation of lockdown restrictions in the current period supported the considerable growth in productivity levels across the Group despite a challenging operating environment in all our markets. Our South African retail segments, Mass and Foundation Cluster, and Personal Finance and Wealth Management continue to deliver improved productivity and issued sales from the low levels in 2020, with issued sales in Personal Finance above 2019 levels due to strong single premium activity. Sales activity in Corporate remained subdued although annuity quotes improved relative to 2020. The South African equities market improved with the JSE SWIX up 17% at the end of the year positively impacting our asset base and associated fee income.

 

In South Africa, high infection rates from the second and third waves of COVID-19 impacted our business and our employees. Personal Finance and Old Mutual Corporate's mortality experience was impacted by higher claims than provided for in the period.

 

In our Rest of Africa markets, there was a gradual return to normal economic activity, which helped sustain the economic growth across the countries. Our Namibia operations were impacted more acutely than the other markets, with an increase in COVID-19 cases and deaths, resulting in poor mortality experience over the period.

 

We have reserved for expected future COVID claims based on experience including the impacts of the Omicron variant. Should a new variant emerge that is more transmissible or result in higher mortality post infection we would have to reassess the provisions held as new facts emerge.

Shareholders are advised that the Group's key profit measures are expected to be within the ranges outlined below:

 

Key Performance Indicators

(R million unless stated otherwise)

 

Estimated

% change

 

Estimated

31 December 2021

 

 

31 December 2020

Results from Operations

>100%

4,301 - 4,467

1,663

Adjusted Headline Earnings

>100%

5,390 - 5,639

2,484

AHEPS (cents)¹

>100%

118 - 128

54.3

1 AHEPS defined as Adjusted Headline Earnings divided by WANS adjusted to reflect the Group's B-BBEE shares and shares held in policyholder and consolidated investment funds.

 

HEPS and Basic EPS are expected to fall within the ranges outlined below:

 

Key Performance Indicators

(R million unless stated otherwise)

 

Estimated

% change

 

Estimated

31 December 2021

 

 

31 December 2020

IFRS profit after tax attributable to equity holders of the parent

>100%

6,519 - 7,029

(5,097)

Basic EPS (cents)

>100%

148 - 160

(116.3)

Headline Earnings

39% to 49%

7,067 - 7,576

5,088

HEPS (cents)

38% to 48%

161 - 172

116.1

 

Shareholders are reminded that the impairments in respect of the carrying value of our investment in Nedbank and the goodwill related to our investment in Old Mutual Finance were recognised in the IFRS income statement in the comparative period and were not repeated. These are however, not recognised in Headline Earnings, and accordingly not recognised in Adjusted Headline Earnings (AHE), as this is an explicit adjusting item in accordance with the JSE Headline Earning Circular 1/2021.

 

Headline earnings is higher than AHE, as AHE excludes higher earnings related to Zimbabwe, partially offset by adjustments in respect of equity and debt instruments held in life funds as well as the impact of restructuring which were lower than FY 2020.

 

The financial information in this trading statement is the responsibility of the Old Mutual Limited Board of Directors and has not been reviewed or reported on by the Group's external auditors.

 

Sandton

 

Sponsors

JSE

Merrill Lynch South Africa (Pty) Limited t/a BofA Securities

Namibia

PSG Wealth Management (Namibia) (Proprietary) Limited

Zimbabwe

Imara Capital Zimbabwe plc

Malawi

Stockbrokers Malawi Limited

 

Enquiries

Investor Relations

Sizwe Ndlovu

Head of Investor Relations

T: +27 (0)11 217 1163

E: tndlovu6@oldmutual.com

 

Communications

Vuyo Mtawa

Head: Group Communications

M: +27 68 422 8125

E: VMtawa@oldmutual.com

 

Notes to Editors

 

About Old Mutual Limited

Old Mutual is a premium African financial services group that offers a broad spectrum of financial solutions to retail and corporate customers across key market segments in14 countries. Old Mutual's primary operations are in South Africa and the Rest of Africa and it has a niche business in Asia. With over 176 years of heritage across sub-Saharan Africa, Old Mutual is a crucial part of the communities they serve and the broader society on the continent.

 

For further information on Old Mutual and its underlying businesses, please visit the corporate website at www.oldmutual.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUOAVRUBUUURR
Date   Source Headline
15th Nov 20221:00 pmRNSForm 8.3 - Mediclinic International plc
11th Nov 20221:30 pmRNSForm 8.3 - Mediclinic International plc
4th Nov 20223:10 pmRNSOld Mutual Bula Tsela Transaction
20th Oct 202212:00 pmRNSForm 8.3 - Mediclinic International plc
14th Oct 202211:00 amRNSForm 8.3 - Mediclinic International plc
13th Oct 202212:30 pmRNSForm 8.3 - Mediclinic International plc
12th Oct 20221:00 pmRNSForm 8.3 - Mediclinic International plc
6th Oct 202212:30 pmRNSForm 8.3 - Mediclinic International plc
29th Sep 20221:30 pmRNSForm 8.3 - Mediclinic International plc
29th Sep 20221:00 pmRNSDirectorate Change
23rd Sep 20223:00 pmRNSForm 8.3 - Mediclinic International plc
6th Sep 202210:30 amRNSDirector/PDMR Shareholding
6th Sep 20229:30 amRNSInterim Dividend Currency Equivalents
30th Aug 20227:00 amRNSUnaudited Interim Results and Dividend Declaration
19th Aug 20222:00 pmRNSForm 8.3 - Mediclinic International plc
16th Aug 202212:40 pmRNSForm 8.3 - Mediclinic International plc
12th Aug 20221:30 pmRNSForm 8.3 - Mediclinic International plc
12th Aug 20221:00 pmRNSResults of shareholder voting at GM
11th Aug 20227:00 amRNSTrading Statement
4th Aug 202212:00 pmRNSForm 8.3 - Mediclinic International plc
27th Jul 20222:30 pmRNSForm 8.3 - Mediclinic International plc
26th Jul 20224:00 pmRNSDirectorate Change
26th Jul 20221:00 pmRNSForm 8.3 - Mediclinic International plc
25th Jul 20221:00 pmRNSForm 8.3 - Mediclinic International plc
19th Jul 20222:00 pmRNSForm 8.3 - Mediclinic International plc
18th Jul 20221:00 pmRNSForm 8.3 - Mediclinic International plc
15th Jul 202211:15 amRNSLiving Hands Trust Matter
13th Jul 20221:00 pmRNSForm 8.3 - Mediclinic International plc
13th Jul 202212:00 pmRNSDistribution of circular including notice of GM
7th Jul 20221:30 pmRNSForm 8.3 - Mediclinic International plc
24th Jun 20223:30 pmRNSHolding(s) in Company
23rd Jun 20222:00 pmRNSForm 8.3 - Mediclinic International plc
22nd Jun 20222:00 pmRNSForm 8.3 - Mediclinic International plc
22nd Jun 202211:45 amRNSOMLACSA new financial instrument
20th Jun 20223:00 pmRNSForm 8.3 - Mediclinic International plc
16th Jun 20221:00 pmRNSForm 8.3 - Mediclinic International plc
15th Jun 20221:00 pmRNSForm 8.3 - Mediclinic International plc
13th Jun 20221:00 pmRNSForm 8.3 - Mediclinic International plc
10th Jun 20224:00 pmRNSForm 8.3 - Mediclinic International plc
6th Jun 20223:45 pmRNSDisposal of Securities by BlackRock. Inc
27th May 202212:15 pmRNSResult of AGM
26th May 202211:00 amRNSOld Mutual Voluntary Operating Update
26th Apr 20222:30 pmRNSNotice of AGM
26th Apr 20229:00 amRNSDirector/PDMR Shareholding
25th Apr 20221:30 pmRNSDealings in Securities
25th Apr 202210:10 amRNSDealings in securities
22nd Apr 20227:00 amRNSRelease of the IR and investor engagement
20th Apr 20222:00 pmRNSOML proposed Bula Tsela B-BBEE transaction
14th Apr 20223:00 pmRNSDealings in Securities on behalf of ESIS
14th Apr 20229:00 amRNSDealings in securities on behalf of ESIS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.